Beijing Jointown Pharmaceutical Co., Ltd. announced that it will receive CNY 300,000,000 in an equity round of funding on August 20, 2016. The transaction will include participation from existing investor, Jointown Pharmaceutical Group Co., Ltd. (SHSE:600998). On closing, the investor will retain its 100% stake in the company. On closing, the registered capital of the company will increase from CNY 245,700,000 to CNY 545,700,000. The transaction was approved at the 14th session of the 3rd directorate of the investor.